VV-Cryoocyte Fund LP
VV-Cryoocyte Fund LP is a venture capital fund based in Concord, Massachusetts. According to its most recent Form D, filed Aug 8, 2017, it has sold $570,000 of interests to 11 investors since its first sale in Nov 2016. The minimum investment it accepts from an outside investor is $10,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Vodia Ventures, LLC; David Matias.
- Total raised
- $570,000Cumulative sales reported on Form D
- Investors
- 11
- First sale
- Nov 23, 2016
- Minimum investment
- $10,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Vodia Ventures, LLC; David Matias
- Latest Form D
- Aug 8, 2017
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about VV-Cryoocyte Fund LP
What is the minimum investment for VV-Cryoocyte Fund LP?
According to its latest Form D, filed Aug 8, 2017, the minimum investment VV-Cryoocyte Fund LP accepts from an outside investor is $10,000.
Who can invest in VV-Cryoocyte Fund LP?
VV-Cryoocyte Fund LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has VV-Cryoocyte Fund LP raised?
VV-Cryoocyte Fund LP reports $570,000 sold from 11 investors on its Form D filed Aug 8, 2017. This is cumulative sales since the offering began, not current assets or performance.
Where is VV-Cryoocyte Fund LP based?
VV-Cryoocyte Fund LP is based in Concord, Massachusetts.
When did VV-Cryoocyte Fund LP launch?
VV-Cryoocyte Fund LP reports its first sale in Nov 2016.
Size compared with every venture capital fund
Raised more than 53% of the 531 venture capital funds based in Massachusetts, and more than 51% of all 14,865 that report sales.